Literature DB >> 18976762

Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis.

Laura P Smith1, Michele R Hacker, Michael M Alper.   

Abstract

OBJECTIVE: To describe our experience with aggressive outpatient transvaginal paracentesis to manage ovarian hyperstimulation syndrome (OHSS).
DESIGN: Retrospective case series.
SETTING: Private, academically affiliated IVF center. PATIENT(S): Women undergoing assisted reproductive technologies (ART) and having a diagnosis of OHSS. INTERVENTION(S): Management of OHSS with hospitalization or outpatient transvaginal paracentesis between 1999 and 2007. MAIN OUTCOME MEASURE(S): Grade and stage of OHSS, need for hospitalization, and adverse events. RESULT(S): From 1999 to 2007, we identified 183 patients with OHSS. We began performing outpatient transvaginal paracentesis to treat OHSS in 2002. We have performed 146 outpatient transvaginal paracenteses in 96 patients with no procedure-related complications. With the implementation of early, aggressive, outpatient paracentesis, the number of patients requiring hospitalization for OHSS decreased. From 2006 to 2007, 29 patients were diagnosed with severe OHSS and 25 (86%) were managed as outpatients with transvaginal paracentesis with no complications. CONCLUSION(S): This report represents one of the largest series of patients with OHSS managed with outpatient transvaginal paracentesis. Although there continues to be a small percentage of patients with OHSS who require hospitalization, the vast majority of patients with severe OHSS at our center in the past 2 years had their condition successfully managed as outpatients with use of aggressive transvaginal paracentesis.

Entities:  

Mesh:

Year:  2008        PMID: 18976762     DOI: 10.1016/j.fertnstert.2008.09.011

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  A new treatment to avoid severe ovarian hyperstimulation utilizing insights from in vitro maturation therapy.

Authors:  B I Rose
Journal:  J Assist Reprod Genet       Date:  2013-12-01       Impact factor: 3.412

2.  Abdominal Compartment Syndrome Due to OHSS.

Authors:  Firoozeh Veisi; Maryam Zangeneh; Shohreh Malekkhosravi; Negin Rezavand
Journal:  J Obstet Gynaecol India       Date:  2013-09-28

3.  Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management.

Authors:  Michael M Alper; Laura P Smith; Eric Scott Sills
Journal:  J Exp Clin Assist Reprod       Date:  2009-06-10

Review 4.  Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment.

Authors:  Klaus Fiedler; Diego Ezcurra
Journal:  Reprod Biol Endocrinol       Date:  2012-04-24       Impact factor: 5.211

5.  Management of severe ovarian hyperstimulation syndrome with thawed plasma.

Authors:  Mohan S Kamath; Asmita Joshi; Anne Marie Kamath; Tk Aleyamma
Journal:  J Hum Reprod Sci       Date:  2013-01

6.  Outpatient Management of Severe Ovarian Hyperstimulation Syndrome (OHSS) with Placement of Pigtail Catheter.

Authors:  M Abuzeid; H Warda; S Joseph; M G Corrado; Y Abuzeid; M Ashraf; B Rizk
Journal:  Facts Views Vis Obgyn       Date:  2014
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.